{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/paronychia-acute/have-i-got-the-right-topic/","result":{"pageContext":{"chapter":{"id":"e855a6e8-ed6f-50da-8601-bb658a2c2142","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","depth":1,"htmlHeader":"<!-- begin field e4ecb55a-3bd2-4c85-8f41-aaab9ca376ec --><h1>Have I got the right topic?</h1><!-- end field e4ecb55a-3bd2-4c85-8f41-aaab9ca376ec -->","summary":null,"htmlStringContent":"<!-- begin item 0ba29599-49dc-47d1-a5e7-4e43c97eeeb9 --><!-- begin field 47c4d80d-5cca-4b44-9b62-acbc015b8bf8 --><p>From age 1 month onwards.</p><!-- end field 47c4d80d-5cca-4b44-9b62-acbc015b8bf8 --><!-- begin field 785ff758-bd3b-4511-8eae-4edd72f13232 --><p>This CKS topic covers the management of acute paronychia.</p><p>This CKS topic does not cover the management of chronic paronychia.</p><p>There are separate CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/fungal-nail-infection/\">Fungal nail infection</a> and <a class=\"topic-reference external-reference\" href=\"/topics/whitlow-staphylococcal-herpetic/\">Whitlow (staphylococcal and herpetic)</a>.</p><p>The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.</p><p>CKS gratefully acknowledges the contribution of the British Association of Dermatologists in the development of this topic.</p><!-- end field 785ff758-bd3b-4511-8eae-4edd72f13232 --><!-- end item 0ba29599-49dc-47d1-a5e7-4e43c97eeeb9 -->","topic":{"id":"b2bb7fc0-a6db-5872-b76f-83f50e0814ee","topicId":"6c8ca646-4291-4610-b32e-02c43d2c8af9","topicName":"Paronychia - acute","slug":"paronychia-acute","lastRevised":"Last revised in January 2021","chapters":[{"id":"9d232456-a0db-59c3-81d2-6066b705f267","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"e855a6e8-ed6f-50da-8601-bb658a2c2142","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b7baf273-3ab9-5b99-91b1-7ff165d7b93e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"118743c0-8ede-55bf-b84a-3f9b8fcebdd8","slug":"changes","fullItemName":"Changes"},{"id":"4ba6812b-5e78-5829-a1ca-8f8a57fe62b4","slug":"update","fullItemName":"Update"}]},{"id":"d477c411-32be-55fe-a86e-08290f4d2b8e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"8c33920b-b3ac-508f-b75a-1eff779e03a1","slug":"goals","fullItemName":"Goals"},{"id":"c4185e18-cda2-5c32-93a0-5c296bd5c060","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f88d0725-e6fd-5377-81c4-23ab93a7caf9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"4f840bc1-0fc7-584f-873e-932c373ceada","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1532db75-44de-553a-9f1e-252b405093a2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"36684520-6e5e-55c7-9b20-a4036334ed13","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a51d8911-5c44-5fbe-891f-7a1ce243e2d0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3b0bcedc-02f6-597c-91c1-68ad812ee098","slug":"definition","fullItemName":"Definition"},{"id":"dbf72d8a-9d7c-5237-9ec4-41564c1723a2","slug":"causes","fullItemName":"Causes"},{"id":"27706fc3-d0b2-517c-a4ca-f9c337526f6e","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"693a21f1-8661-5aa0-a4ad-4fd293690c1f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a7b667a2-77ed-58ce-85e1-28053b3cbac6","slug":"complications","fullItemName":"Complications"},{"id":"69b0affa-ba11-50c0-b7eb-4164215fff81","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"402635e2-8b5b-510b-8911-de663be26627","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"d2b9d442-db59-5ce2-8001-f79b47a0d07b","slug":"clinical-presentation","fullItemName":"Clinical presentation"},{"id":"5fefa9cc-3cd1-5fe6-97c9-b95e84cf7790","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"d056845a-158d-5904-925f-c1f2590f7c8c","fullItemName":"Management","slug":"management","subChapters":[{"id":"2f065baa-02b7-57a9-a6f9-036079cc78af","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"b8188aa3-5a20-53fc-9ac5-f1500bcb20ee","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a2fead58-dca1-5103-8ad8-61ea6110cd3e","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"0ba4b7a5-9a25-5970-b668-a9c7c4fb38af","slug":"clarithromycin","fullItemName":"Clarithromycin"},{"id":"17d25ace-76d2-5ab6-ac1d-8a1238ea8e09","slug":"erythromycin","fullItemName":"Erythromycin"}]},{"id":"6e2d0756-59aa-5521-b157-730945914705","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f5ecaf87-1d35-5c33-8736-46baa81bda4e","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"9235cf50-84ce-54e7-b840-58aa133fc328","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"592eaa54-938e-528f-ac4e-1f2d1e7bf7b7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"37214d7d-d933-54be-90ef-dc6fabcc7943","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"599ff9f8-a29d-5b76-9429-6e0788baf48f","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a58d49de-b64c-5e6e-8c5b-5c60f36f832c","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2bc165bd-1fb7-56b2-8b43-476ce2b9c4a2","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}